ABCL - AbCellera Biologics Inc.
3.45
-0.140 -4.058%
Share volume: 4,246,409
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$3.59
-0.14
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-04-2024 | 02-27-2025 | 05-08-2025 | 11-06-2025 | 02-24-2026 | |
| Cash flow financing | 2.831 M | 2.651 M | 3.145 M | 4.142 M | 5.970 M | 7.372 M | 4.115 M | |
| Other financing cash flows | 707.000 K | 278.000 K | 43.000 K | 11.741 M | 5.970 M | 7.372 M | 4.115 M | |
| Cash flow | -8.967 M | 24.783 M | -22.039 M | 31.845 M | 2.351 M | -8.734 M | 44.510 M | |
| Net income | -40.610 M | -36.930 M | -51.107 M | -34.210 M | -45.621 M | -57.119 M | -8.945 M | |
| Depreciation | 3.155 M | 3.448 M | 3.834 M | 2.100 M | 4.409 M | 4.306 M | 5.182 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 29.910 M | 52.098 M | 3.698 M | 35.703 M | 7.935 M | 36.488 M | 75.138 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 7.168 M | 12.582 M | 9.400 M | 6.558 M | 1.018 M | 918.000 K | 44.090 M | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 24.140 M | 20.110 M | 18.516 M | 15.630 M | 10.636 M | 8.928 M | 9.843 M | |
| Cash Change | -9.748 M | 24.740 M | -21.672 M | 29.685 M | 2.941 M | -9.278 M | 44.800 M |